-
1دورية أكاديمية
المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I
المصدر: Human Vaccines & Immunotherapeutics. 10(11)
مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, immunotherapy, MPDL3280A, melanoma, nivolumab, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, gp100, glycoprotein 100 vaccine, Ig, immunoglobulin, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, programmed cell death 1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, Ig, immunoglobulin, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, PD-1, programmed cell death 1, PD-L1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, gp100, glycoprotein 100 vaccine, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/49q8w2djTest
-
2دورية أكاديمية
المؤلفون: Sarah L Scarpace
المصدر: Drugs in Context, Pp 1-7 (2015)
مصطلحات موضوعية: carcinoma, squamous cell, non-small-cell lung cancer, immunotherapy, molecular targeted therapy, antibodies, monoclonal, nivolumab, pembrolizumab, cisplatin, carboplatin, gemcitabine, pemetrexed, ramucirumab, bevacizumab, programmed cell death-1 receptor, avelumab, MSB0010718C, MPDL3280A, MEDI4736, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: http://www.drugsincontext.com/metastatic-squamous-cell-non-small-cell-lung-cancer-nsclc-disrupting-the-drug-treatment-paradigm-with-immunotherapiesTest/; https://doaj.org/toc/1740-4398Test
-
3
المؤلفون: Jedd D. Wolchok, David B. Page, Jarushka Naidoo
المصدر: British Journal of Cancer
مصطلحات موضوعية: Cancer Research, anti-PD-L1, medicine.medical_treatment, Ipilimumab, Immune system, tremelimumab, Antigen, Neoplasms, medicine, Humans, Antibody-dependent cell-mediated cytotoxicity, nivolumab, anti-CTLA4, business.industry, Immunotherapy, BMS-936559, Immune checkpoint, Oncology, MPDL3280A, Immunology, anti-PD-1, Minireview, Nivolumab, business, Tremelimumab, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d6166bdfa37af6284efa3ef85ad2b5Test
http://europepmc.org/articles/PMC4264429Test -
4دورية أكاديمية
المؤلفون: Scheel, Andreas H., Ansen, Sascha, Schultheis, Anne M., Scheffler, Matthias, Fischer, Rieke N., Michels, Sebastian, Hellmich, Martin, George, Julie, Zander, Thomas, Brockmann, Michael, Stoelben, Erich, Groen, Harry, Timens, Wim, Perner, Sven, von Bergwelt-Baildon, Michael, Buettner, Reinhard, Wolf, Juergen
المصدر: Scheel , A H , Ansen , S , Schultheis , A M , Scheffler , M , Fischer , R N , Michels , S , Hellmich , M , George , J , Zander , T , Brockmann , M , Stoelben , E , Groen , H , Timens , W , Perner , S , von Bergwelt-Baildon , M , Buettner , R & Wolf , J 2016 , ' PD-L1 expression in non-small cell lung cancer : Correlations with genetic alterations ' , OncoImmunology , vol. 5 , no. 5 , 1131379 . https://doi.org/10.1080/2162402X.2015.1131379Test
مصطلحات موضوعية: Checkpoint inhibition, early stage NSCLC, genetic alterations, immunohistochemistry, non-small cell lung cancer, PD-L1, 5H1, DEATH-LIGAND 1, ANTIBODY MPDL3280A, BREAST-CANCER, NIVOLUMAB, MELANOMA, IMMUNE, TUMOR, B7-H1, ADENOCARCINOMA, PEMBROLIZUMAB
الإتاحة: https://doi.org/10.1080/2162402X.2015.1131379Test
https://hdl.handle.net/11370/45183bcf-9331-4a75-bb12-06f86907305bTest
https://research.rug.nl/en/publications/45183bcf-9331-4a75-bb12-06f86907305bTest -
5
المؤلفون: Juergen Wolf, Rieke Fischer, Michael Brockmann, Thomas Zander, Julie George, Sascha Ansén, Wim Timens, Michael von Bergwelt-Baildon, Anne M. Schultheis, Erich Stoelben, Matthias Scheffler, Reinhard Buettner, Harry J.M. Groen, Andreas H. Scheel, Sven Perner, Sebastian Michels, Martin Hellmich
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Groningen Research Institute for Asthma and COPD (GRIAC)
المصدر: OncoImmunology, 5(5):1131379. Taylor & Francis Group
مصطلحات موضوعية: 0301 basic medicine, Oncology, PD-L1, medicine.medical_specialty, early stage NSCLC, DEATH-LIGAND 1, medicine.medical_treatment, Immunology, IMMUNE, MELANOMA, Pembrolizumab, Biology, medicine.disease_cause, ANTIBODY MPDL3280A, 03 medical and health sciences, 5H1, 0302 clinical medicine, TUMOR, Internal medicine, Checkpoint inhibition, medicine, Immunology and Allergy, BREAST-CANCER, Lung cancer, PEMBROLIZUMAB, non-small cell lung cancer, Original Research, genetic alterations, Melanoma, NIVOLUMAB, ADENOCARCINOMA, Immunotherapy, medicine.disease, B7-H1, 030104 developmental biology, 030220 oncology & carcinogenesis, immunohistochemistry, Cancer research, biology.protein, Adenocarcinoma, KRAS, Antibody
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4fe71ef809691242aa09ab32f1d86cfTest
https://research.rug.nl/en/publications/45183bcf-9331-4a75-bb12-06f86907305bTest -
6دورية أكاديمية
المؤلفون: Ngiow, Shin Foong, Young, Arabella, Jacquelot, Nicolas, Yamazaki, Takahiro, Enot, David, Zitvogel, Laurence, Smyth, Mark J.
مصطلحات موضوعية: Fc-Gamma-Riii, Regulatory T, Pd-1 Blockade, Nivolumab, Antibody, Checkpoints, Increases, Rejection, Mpdl3280A, Melanoma, 1306 Cancer Research, 2730 Oncology
العلاقة: orcid:0000-0001-7098-7240; 628623; 1078671; Not set